The Effect of Compound Rehmannia Prescription on the Expression of GDNF in LD Ra Ts with Parkinson′s Disease

Ding Hong
2011-01-01
Abstract:Objective To approach the effect of compound rehmannia prescription on the expression of G DNF in LD rats with Parkinson′s disease(PD).Methods The c lassic method was used to establish the PD model rats through stereotoxic inject ion of 6-OHDA,then injected intraperitoneally Levodopa/benserazide for 2 w to e s tablish the model of rats with toxic and side effects of Levodopa in PD(to call LD model for short).The successful LD models were randomized into LD model and compound rehmannia prescription groups,and normal control,sham-operated and PD model control groups were brought into,18 rats for each group.Then,the express i on of GDNF in striatum by immunohistochemistry in different time were observed about 2,4,6 w.Results ①From the same time,the exp r ession of GDNF in LD model,compound rehmannia prescription and PD model control groups were lower than those of normal control and sham-operated groups(P 0.01,P0.001);and it was higher in compound rehmannia prescription gr ou p than that of LD model and PD model control groups(P0.001);and it wa s lower in LD model group than that in PD model control group(P0.01,P 0.001).②From the different time,with the time by,the expression of GDNF w as gradually decreased in LD model group,and there was significant difference at 6 w compared with that at 2 w,4 w(P0.001);but the expression of GDNF i n c ompound rehmannia prescription group was gradually increased,and there was sign ificant difference at 6 w compared with that at 2 w,4 w(P0.001);PD mo de l control group was no significant(P0.05).Conclusi ons Compound rehmannia prescription could obviously increase the exp ression of GDNF in striatum of LD rats with PD,and reduce the DA neuron death,to lighten the toxic and side effects of Levodopa.
What problem does this paper attempt to address?